Almorexant clinical trials
How each study uses almorexant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 1
Midnight Pharma, LLC (3) · Northern California Institute of Research and Education (1)
Studies
Open first, then newest update. How each study uses almorexant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Almorexant (ACT 078573) in Adult Subjects With Chronic Primary InsomniaCompletedPhase 3Midnight Pharma, LLCNCT00608985Written as almorexantHow we know
- Almorexant in Primary InsomniaCompletedPhase 1Midnight Pharma, LLCNCT00640848Written as almorexantHow we know
- Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug UsersCompletedPhase 1Midnight Pharma, LLCNCT01987739Written as 200 mg almorexantHow we know
- Effect of a Hypocretin/Orexin Antagonist on Neurocognitive PerformanceCompletedNot applicableNorthern California Institute of Research and EducationNCT01243060Written as AlmorexantHow we know
Given beside what is tested · 1 — almorexant is usual care or a partner of the new treatment
Codes
What other systems call almorexant · ClinicalTrials.gg INT005073
- MeSH (NLM) C519150almorexantOne source NLM
- UNII (FDA) 9KCW39P2EIALMOREXANTConfirmed FDA, NLM, Wikidata
- Wikidata Q4355941almorexantConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87423AlmorexantOne source FDA
- DrugBank DB06673One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C519150 | almorexant | One source NLM |
| UNII (FDA) | 9KCW39P2EI | ALMOREXANT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q4355941 | almorexant | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87423 | Almorexant | One source FDA |
| DrugBank | DB06673 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.